New Research Poster Presentation 3.34
Phosphorus Magnetic Resonance Spectroscopy (31P-MRS) Study of Dose-Ranging, Placebo-Controlled Creatine Augmentation for Adolescent Females With Serotonin-Specific Reuptake Inhibitor-Resistant (SSRI-Resistant) Major Depressive Disorder

Thursday, October 23, 2014 1:00 PM
Douglas G. Kondo, MD, Diagnostic Neuroimaging, University of Utah, Salt Lake City, UT
Lauren N. Forrest, BS, Diagnostic Neuroimaging, University of Utah, Salt Lake City, UT
Xianfeng Shi, PhD, Diagnostic Neuroimaging, University of Utah, Salt Lake City, UT
Perry F. Renshaw, MD, MBA, PhD, Diagnostic Neuroimaging, University of Utah, Salt Lake City, UT
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.